OpenAI is participating in a $250 million seed round into Merge Labs, Sam Altman's brain computer interface startup. The ...
Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback